Transcriptomic Analysis Reveals Priming of The Host Antiviral Interferon Signaling Pathway by Bronchobini® Resulting in Balanced Immune Response to Rhinovirus Infection in Mouse Lung Tissue Slices
Open Access
- 7 May 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (9) , 2242
Abstract
Rhinovirus (RV) is the predominant virus causing respiratory tract infections. Bronchobini® is a low dose multi component, multi target preparation used to treat inflammatory respiratory diseases such as the common cold, described to ease severity of symptoms such as cough and viscous mucus production. The aim of the study was to assess the efficacy of Bronchobini® in RV infection and to elucidate its mode of action. Therefore, Bronchobini®’s ingredients (BRO) were assessed in an ex vivo model of RV infection using mouse precision-cut lung slices, an organotypic tissue capable to reflect the host immune response to RV infection. Cytokine profiles were assessed using enzyme-linked immunosorbent assay (ELISA) and mesoscale discovery (MSD). Gene expression analysis was performed using Affymetrix microarrays and ingenuity pathway analysis. BRO treatment resulted in the significant suppression of RV-induced antiviral and pro-inflammatory cytokine release. Transcriptome analysis revealed a multifactorial mode of action of BRO, with a strong inhibition of the RV-induced pro-inflammatory and antiviral host response mediated by nuclear factor kappa B (NFkB) and interferon signaling pathways. Interestingly, this was due to priming of these pathways in the absence of virus. Overall, BRO exerted its beneficial anti-inflammatory effect by priming the antiviral host response resulting in a reduced inflammatory response to RV infection, thereby balancing an otherwise excessive inflammatory response.Keywords
This publication has 73 references indexed in Scilit:
- Productive Entry Pathways of Human RhinovirusesAdvances in Virology, 2012
- Defining critical roles for NF‐κB p65 and type I interferon in innate immunity to rhinovirusEMBO Molecular Medicine, 2012
- Clinical and molecular features of human rhinovirus CMicrobes and Infection, 2012
- Pathogenesis of rhinovirus infectionCurrent Opinion in Virology, 2012
- Proinflammatory Actions of Visfatin/Nicotinamide Phosphoribosyltransferase (Nampt) Involve Regulation of Insulin Signaling Pathway and Nampt Enzymatic ActivityJournal of Biological Chemistry, 2012
- Type I Interferons Regulate Cytolytic Activity of Memory CD8+ T Cells in the Lung Airways during Respiratory Virus ChallengeImmunity, 2010
- A20: Central Gatekeeper in Inflammation and ImmunityJournal of Biological Chemistry, 2009
- Multiple receptors involved in human rhinovirus attachment to live cellsProceedings of the National Academy of Sciences, 2008
- Human Rhinovirus 1B Exposure Induces Phosphatidylinositol 3-Kinase–dependent Airway Inflammation in MiceAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammationNature Medicine, 2008